Macrogenics (MGNX) Gross Profit (2020 - 2026)
Macrogenics' Gross Profit was $11.25 million in Q1 2026, up 44.3% from $7.79 million a year earlier but down 63.9% from the prior quarter.
Powered by 
Analysis
Macrogenics (MGNX) Gross Profit (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Macrogenics' Gross Profit was $101.57 million through Mar 31, 2026, down 27.0% year-over-year; for FY2025, it came in at $113.49 million, down 18.1% from FY2024.
- Gross Profit shows a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
- In earlier years, Gross Profit was $138.51 million in FY2024 (+170.8%), $51.15 million in FY2023 (-65.4%), $147.91 million in FY2022 (+97.7%) and $74.8 million in FY2021 (-28.7%).
- Quarterly Gross Profit has moved between -$2.04 million (Q2 2025) and $109.01 million (Q3 2024) over five years.
- Compared with a year earlier, Gross Profit was higher in four of the last six quarters, with growth averaging 21.1%.
- The best year-over-year quarter for Gross Profit over five years was Q4 2022 (growth of 447.7%); the worst was Q4 2023 (a decline of 85.2%).
- Per Business Quant data, MGNX's Gross Profit in the three quarters before Q1 2026 was $31.11 million (Q4 2025), $61.25 million (Q3 2025) and -$2.04 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Macrogenics | 245.67 Mn | -72.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 11.25 Mn |
| Dec 31, 2025 | 31.11 Mn |
| Sep 30, 2025 | 61.25 Mn |
| Jun 30, 2025 | -2.04 Mn |
| Mar 31, 2025 | 7.79 Mn |
| Dec 31, 2024 | 14.10 Mn |
| Sep 30, 2024 | 109.01 Mn |
| Jun 30, 2024 | 8.15 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Sep 30, 2023 | 7.12 Mn |
| Jun 30, 2023 | 12.22 Mn |
| Mar 31, 2023 | 21.09 Mn |
| Dec 31, 2022 | 72.30 Mn |
| Sep 30, 2022 | 38.73 Mn |
| Jun 30, 2022 | 23.79 Mn |
| Mar 31, 2022 | 11.05 Mn |
| Dec 31, 2021 | 13.20 Mn |
| Sep 30, 2021 | 14.00 Mn |
| Jun 30, 2021 | 30.74 Mn |
API Access
Macrogenics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=MGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "MGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=MGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();